Document:

Exhibit 10.2

 

	
        ADDENDUM
        NO. 1

        TO
        AGREEMENT No. 97 1020 1026 0000 1702 0388 9318

        OVERDRAFT
        FACILITY 

        OF
        23 May 2019 (“AGREEMENT”)
	 

 

The Agreement is made on the day it is
signed by the last of the parties’ representatives.

 

Powszechna Kasa Oszczędności
Bank Bank Polski Spółka Akcyjna with its registered office in Warsaw, address: ul. Puławska 15, 02-515 Warsaw,
registered under KRS number 0000026438 in the District Court for the Capital City of Warsaw, 13th Commercial Division of the National
Court Register, Tax ID: PLN 525-000-77-38, REGON (stat. ID): 016298263, share capital (paid-in capital) PLN 1,250,000,000.00 (PKOBP
SA), represented by:

 

		1.	Paweł Krzywdziuk – Proxy,

 

		2.	Renata Kwotek – Proxy,

 

and

ASEC Joint Stock Company with its
registered office in Krakow, address: ul. Wadowicka 6, 30-415 Kraków, registered in the District Court for Krakow-Śródmieście
in Krakow, 11th Commercial Division of the National Court Register under KRS number 0000034383, Tax ID: 677-193-09-64, REGON: 351324446,
share capital(paid capital) PLN 4107,000.00 ( “Borrower”), represented by:

 

		1.	Agnieszka Światły –CEO

 

		2.	Tomasz Boryczko – Member of the Board,

 

(collectively, “Parties”),
make this Addendum No. 1 (“Addendum”) to the Agreement, to read as follows:

 

§ 1

 

1. The Parties agree to amend the Agreement to the following
extent:

 

1) the loan term and the utilization term shall be extended
by 6 (six) months, i.e. until November 22, 2020, starting from the day following the last day of the loan term and the utilization
term indicated in the existing provisions of the Agreement;

 

2) both the utilization term and the loan repayment term expire
on the last day of the loan term, in accordance with item 1 above,

 

3) in § 7 para. 3 item 1 shall be amended to read as follows:

 

“1) submitting the documents, in the originals, required
by the law and copies of the documents that have been provided using the electronic channel, i.e. by e-mail from the Borrower’s
e-mail address: molszewska@otieuropa.com and aswiatly@otieuropa.com at each request of PKO BP SA, no later, however, than in within
7 (say: seven) days from the date of such request by PKO BP SA. “;

 

4) in § 8 point 7 shall be amended to read as follows:

 

“7) all copies of documents provided in connection with
the Agreement by email from the Borrower’s email address molszewska@otieuropa.com and aswiatly@otieuropa.com are a faithful representation
of the original documents in the Borrower’s permanent possession, and the Borrower is aware of criminal liability for providing
false information regarding the documents provided in this way and the responsibility for the actions of the persons the Borrower
entrusted with providing the copies of the documents by e-mail from the abovementioned email address.”;

 

5) § 13 para. 2 item 1 shall be amended to read as follows:

 

“1) to PKO BP SA:

Powszechna Kasa Oszczędności Bank Polski Spółka
Akcyjna

1st Regional Corporate Center in Warsaw,

ul. Chłodna 52,

00-872 Warsaw,

Phone number: 22 597 41 14

e-mail pawel.krzywdziuk@pkobp.pl; RCK.I.Warszawa@pkpb.pl

or another of which PKO BP SA may notify the Borrower no less
than five business days in advance. “

 

2. The Borrower hereby confirms that all representations, warranties
and obligations made by the Borrower in the Agreement remain true, effective and valid as at the date of signing the Addendum.

 

3. The Borrower declares that all collaterals established by
the Borrower for the obligations arising from the Agreement remain in force.

 

§ 2

 

The other provisions of the Agreement shall remain unchanged.

 

§ 3

 

Due to the conclusion of the Addendum, PKO BP SA shall collect,
without a separate instruction from the Borrower, the applicable commissions and bank fees in the amounts specified in the Agreement,
in an amount proportional to the extended loan term. The bank commissions and fees shall be collected on the day of conclusion
of the Addendum, in the manner specified in the Agreement, for which the Borrower hereby authorizes PKO BP SA.

 

§ 4.

 

The Addendum shall form an integral part
of the Agreement and shall come into force on the day on which it is signed.

 

§ 5

 

    1

     

    

 

1. The Addendum is made in 2 (two) counterparts,
1 (one) for each of the Parties hereto.

 

2. This document is made / the declaration
of intent is made by the proxy in electronic format and signed with qualified electronic signatures using qualified certificates,
in accordance with the provisions of the Act of 5 September 2016 on Trust Services and Electronic Identification.

 

	Signatures of persons acting on behalf of the Borrower:	 	Signatures of persons acting on behalf of PKO BP SA:
	 	 	 
	Signed by: 	 	Signed by: 
	 	 	 
	/s/ Agnieszka Światły	 	/s/ Renata Elzbieta Kwitek
	Agnieszka Światły, CEO	 	Renata Elzbieta Kwitek, Proxy
	Date: 5.11.2020 2:16 p.m. 	 	Date: 5.11.2020 2:48 p.m.
	 	 	 
	Signed by: 	 	 
	 	 	 
	/s/ Tomasz Stanisław Boryczko 	 	 
	Tomasz Stanisław Boryczko, Member of the Board	 	 
	Date: 5.11.2020 2:23 p.m. 	 	 

 

 

2Ex10_1

		

			Exhibit 10.1

		

		
			BioXcel Therapeutics, Inc.
		

		
			 
		

		
			Non-Employee Director Compensation Program
		

		
			 
		

		
			Non-employee members of the board of directors (the “Board”) of BioXcel Therapeutics, Inc. (the “Company”) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this “Program”).  The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a “Non-Employee Director”) who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company and subject to any limits on non-employee director compensation set forth in the Equity Plan (as defined below).  This Program shall remain in effect until it is revised or rescinded by further action of the Board.  This Program may be amended, modified or terminated by the Board at any time in its sole discretion.  The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors, except for equity compensation previously granted to a Non-Employee Director.    
		

		
			Cash Compensation
		

		
			The schedule of annual retainers (the “Annual Retainers”) for the Non-Employee Directors is as follows:
		

			
					
						 

					
					
						 

				
	
					
						Position

					
					
						Amount

				
	
					
						Base Board Fee

					
					
						$60,000

				
	
					
						Chair of the Board or Lead Independent Director

					
					
						$30,000

				
	
					
						Chair of Audit Committee

					
					
						$20,000

				
	
					
						Chair of Compensation Committee

					
					
						$10,000

				
	
					
						Chair of Nominating and Corporate Governance Committee

					
					
						$7,000

				
	
					
						Member of Audit Committee (non-Chair)

					
					
						$7,500

				
	
					
						Member of Compensation Committee (non-Chair)

					
					
						$5,000

				
	
					
						Member of Nominating and Corporate Governance Committee (non-Chair)

					
					
						$3,500

				

		
			 
		

		
			
		

		
			

		 

		

			1

		

		

		
			For the avoidance of doubt, the Annual Retainers in the table above are additive and a Non-Employee Director shall be eligible to earn an Annual Retainer for each position in which he or she serves. The Annual Retainers shall be earned on a quarterly basis based on a calendar quarter and shall be paid in cash by the Company in arrears not later than the fifteenth day following the end of each calendar quarter.  In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the applicable position, for an entire calendar quarter, the retainer paid to such Non-Employee Director shall be prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as applicable.    
		

		
			 
		

		
			Equity Compensation 
		

		
			Each Non-Employee Director shall be granted options to purchase shares of the Company’s common stock (each, an “Option”) as set forth in this Program. Each Option shall be granted under and subject to the terms and provisions of the Company’s 2020 Incentive Award Plan or any other applicable Company equity incentive plan then-maintained by the Company (the “Equity Plan”) and shall be subject to an award agreement, including attached exhibits, in substantially the form previously approved by the Board.  
		

		
			A.         Option Grant.  A Non-Employee Director who (i) is initially elected or appointed to the Board at an annual meeting of the Company’s stockholders or (ii) has been serving as a Non-Employee Director on the Board as of the date of any annual meeting of the Company’s stockholders and will continue to serve as a Non-Employee Director immediately following such meeting, shall be automatically granted an Option to purchase 20,000 shares of the Company’s common stock on the date of such annual meeting.    
		

		
			 
		

		
			B.         Terms of Options Granted to Non-Employee Directors.
		

		
			1.         Exercise Price.  The per-share exercise price of each Option granted to a Non-Employee Director shall equal the Fair Market Value (as defined in the Equity Plan) of a share of the Company’s common stock on the date the Option is granted. 
		

		
			2.         Vesting.  Each Option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Company’s stockholders occurring after the date of grant, in either case, subject to the Non-Employee Director continuing in service as a Non-Employee Director through such vesting date.   
		

		
			3.         Forfeiture of Options.  Unless the Board otherwise determines, any portion of an Option which is unvested or unexercisable at the time of a Non-Employee Director’s termination of service on the Board as a Non-Employee Director shall be immediately forfeited upon such termination of service and shall not thereafter become vested and exercisable.  All of a Non-Employee Director’s Options shall vest in full immediately prior to the occurrence of a Change in Control (as defined in the Equity Plan), to the extent outstanding at such time.
		

		
			

		 

		

			2

		

		

		
			4.         Term.  The maximum term of each Option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the Option is granted.
		

		
			* * * * *
		

		 

		

			3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]